查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1729264

日本抗生素市场报告（按作用机制、药物类别、活性范围、给药途径、最终用户和地区划分）2025-2033

Japan Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 118 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024 年，日本抗生素市场规模达 31.52 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 58.51 亿美元，2025-2033 年期间的成长率 (CAGR) 为 7.1%。传染病的盛行率不断上升，导致手术、医疗程序和住院治疗，从而增加了对预防和治疗此类疾病的抗生素的需求，这是推动市场发展的主要因素。

抗生素是用于治疗细菌感染的强效药物。它们透过瞄准并杀死细菌或抑制其生长来发挥作用。抗生素可分为几类，每类都有其独特的作用机转。这些药物都是由医疗保健专业人员在诊断出细菌感染后开出的。按照指示使用抗生素并完成规定的疗程对于确保彻底消灭细菌至关重要。如果不这样做，可能会导致抗生素抗药性，即细菌对这些药物的敏感性降低。虽然抗生素对细菌有效，但对普通感冒或流感等病毒感染无效。抗生素的过度使用或滥用引发了人们对抗生素抗药性菌株发展的担忧，因此必须谨慎使用抗生素，并且只在必要时才使用。为了对抗不断演变的细菌威胁，对新型抗生素和替代疗法的研究仍然是医疗保健领域关注的关键领域。

日本抗生素市场趋势：

多年来，日本抗生素市场经历了显着成长，有几个关键驱动因素推动了这一上升趋势。首先，细菌感染的增加必然导致抗生素需求的增加。此外，老年人口的增加（他们更容易受到感染）进一步加剧了这种需求。此外，生物技术方法的进步导致了新型抗生素的发现，从而扩大了市场。此外，抗生素抗药性病原体的传播使得对研发的投资变得紧迫，从而推动该领域的更多创新和发展。值得注意的是，政府和私人实体不断增加的支持和资金对于推动研究计画至关重要。另一个关键因素是人们对细菌感染及其影响的认识不断提高，加上医疗设施的便利性。因此，抗生素处方量稳定成长，促进了市场发展。另一方面，儘管有效治疗方案的必要性毋庸置疑，但人们担心抗生素的过度使用可能会导致抗药性。儘管如此，对有效抗菌治疗的整体需求仍然至关重要，这些市场驱动因素在塑造产业格局方面发挥着至关重要的作用。

日本抗生素市场区隔：

作用机制洞察：

  • 细胞壁合成抑制剂
  • 蛋白质合成抑制剂
  • DNA合成抑制剂
  • RNA合成抑制剂
  • 肌酸抑制剂
  • 其他的

药物类别洞察：

  • 头孢菌素
  • 青霉素
  • 氟喹诺酮类药物
  • 大环内酯类
  • 卡巴培南
  • 氨基糖苷类
  • 其他的

活动洞察范围：

  • 广效抗生素
  • 窄谱抗生素

给药途径洞察：

  • 口服
  • 肠外
  • 外用
  • 其他的

最终用户洞察：

  • 医院
  • 专科诊所
  • 其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本抗生素市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本抗生素市场有何影响？
  • 日本抗生素市场依作用机制如何划分？
  • 日本抗生素市场依药品类别如何划分？
  • 根据活动范围，日本抗生素市场是如何分類的？
  • 根据给药途径，日本抗生素市场是如何分類的？
  • 根据最终用户，日本抗生素市场的分布是怎样的？
  • 日本抗生素市场的价值链分为哪些阶段？
  • 日本抗生素的关键驱动因素和挑战是什么？
  • 日本抗生素市场的结构是怎么样的？主要参与者是谁？
  • 日本抗生素市场的竞争程度如何？

本报告回答的关键问题：

  • 日本抗生素市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本抗生素市场有何影响？
  • 日本抗生素市场依作用机制如何划分？
  • 日本抗生素市场依药品类别如何划分？
  • 根据活动范围，日本抗生素市场是如何分類的？
  • 根据给药途径，日本抗生素市场是如何分類的？
  • 根据最终用户，日本抗生素市场的分布是怎样的？
  • 日本抗生素市场的价值链分为哪些阶段？
  • 日本抗生素的关键驱动因素和挑战是什么？
  • 日本抗生素市场的结构是怎么样的？主要参与者是谁？
  • 日本抗生素市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本抗生素市场－简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本抗生素市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本抗生素市场-细分：按作用机制

  • 细胞壁合成抑制剂
    • 概述
  • 蛋白质合成抑制剂
    • 概述
  • DNA合成抑制剂
    • 概述
  • RNA合成抑制剂
    • 概述
  • 肌酸抑制剂
    • 概述
  • 其他的

第七章：日本抗生素市场-细分：依药物类别

  • 头孢菌素
    • 概述
  • 青霉素
    • 概述
  • 氟喹诺酮类药物
    • 概述
  • 大环内酯类
    • 概述
  • 卡巴培南
    • 概述
  • 氨基糖苷类
    • 概述
  • 其他的

第 8 章：日本抗生素市场 - 细分：依活动范围

  • 广效抗生素
    • 概述
  • 窄谱抗生素
    • 概述

第九章：日本抗生素市场-细分：依给药途径

  • 口服
    • 概述
  • 肠外
    • 概述
  • 外用
    • 概述
  • 其他的

第 10 章：日本抗生素市场 - 细分：按最终用户

  • 医院
    • 概述
  • 专科诊所
    • 概述
  • 其他的

第 11 章：日本抗生素市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第 12 章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第十三章：日本抗生素市场-产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 14 章：附录

简介目录
Product Code: SR112025A18083

Japan antibiotics market size reached USD 3,152 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 5,851 Million by 2033, exhibiting a growth rate (CAGR) of 7.1% during 2025-2033. The escalating prevalence of infectious diseases, which also leads to surgeries, medical procedures, and hospitalizations, thereby increasing the need for antibiotics to prevent and treat such conditions, is primarily driving the market.

Antibiotics are powerful medications used to treat bacterial infections. They work by targeting and killing bacteria or inhibiting their growth. Antibiotics can be categorized into several classes, each with its unique mechanism of action. They are prescribed by healthcare professionals after diagnosing a bacterial infection. It's crucial to use antibiotics as directed and complete the prescribed course to ensure the complete eradication of bacteria. Failure to do so can lead to antibiotic resistance, where bacteria become less responsive to these drugs. While antibiotics are effective against bacteria, they do not work on viral infections like the common cold or flu. Overuse or misuse of antibiotics has raised concerns about the development of antibiotic-resistant strains of bacteria, making it essential to use them judiciously and only when necessary. Research into new antibiotics and alternative treatments continues to be a critical area of focus in healthcare to combat evolving bacterial threats.

Japan Antibiotics Market Trends:

The antibiotics market in Japan has witnessed significant growth over the years, and several key drivers have propelled this upward trajectory. Firstly, the rise in bacterial infections has necessitated an increased demand for antibiotics. Additionally, the expansion of the geriatric population, which is more susceptible to infections, has further fueled this need. Moreover, advancements in biotechnological methods have led to the discovery of novel antibiotics, thus expanding the market. Furthermore, the spread of antibiotic-resistant pathogens has created an urgency to invest in R&D, leading to more innovations and developments in the sector. Notably, the increasing support and funding from both government and private entities have been pivotal in pushing forward research initiatives. Another crucial factor is the growing awareness among people about bacterial infections and their implications, coupled with easy access to healthcare facilities. Consequently, there is a steady growth in antibiotic prescriptions, boosting the market. On the other hand, though the need for effective treatment regimens is undeniable, there are concerns about antibiotic overuse, potentially causing resistance. Nevertheless, the overall need for effective antibacterial treatments remains paramount, and these market drivers play a crucial role in shaping the industry's landscape.

Japan Antibiotics Market Segmentation:

Action Mechanism Insights:

  • Cell Wall Synthesis Inhibitors
  • Protein Synthesis Inhibitors
  • DNA Synthesis Inhibitors
  • RNA Synthesis Inhibitors
  • Mycolic Acid Inhibitors
  • Others

Drug Class Insights:

  • Cephalosporin
  • Penicillin
  • Fluoroquinolone
  • Macrolide
  • Carbapenem
  • Aminoglycoside
  • Others

Spectrum of Activity Insights:

  • Broad-Spectrum Antibiotics
  • Narrow-Spectrum Antibiotics

Route of Administration Insights:

  • Oral
  • Parenteral
  • Topical
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan antibiotics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan antibiotics market?
  • What is the breakup of the Japan antibiotics market on the basis of action mechanism?
  • What is the breakup of the Japan antibiotics market on the basis of drug class?
  • What is the breakup of the Japan antibiotics market on the basis of spectrum of activity?
  • What is the breakup of the Japan antibiotics market on the basis of route of administration?
  • What is the breakup of the Japan antibiotics market on the basis of end user?
  • What are the various stages in the value chain of the Japan antibiotics market?
  • What are the key driving factors and challenges in the Japan antibiotics?
  • What is the structure of the Japan antibiotics market and who are the key players?
  • What is the degree of competition in the Japan antibiotics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Antibiotics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Antibiotics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Antibiotics Market - Breakup by Action Mechanism

  • 6.1 Cell Wall Synthesis Inhibitors
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Protein Synthesis Inhibitors
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 DNA Synthesis Inhibitors
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 RNA Synthesis Inhibitors
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Mycolic Acid Inhibitors
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 Others
    • 6.6.1 Historical and Current Market Trends (2019-2024)
    • 6.6.2 Market Forecast (2025-2033)

7 Japan Antibiotics Market - Breakup by Drug Class

  • 7.1 Cephalosporin
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Penicillin
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Fluoroquinolone
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Macrolide
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Carbapenem
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Aminoglycoside
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2019-2024)
    • 7.6.3 Market Forecast (2025-2033)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2019-2024)
    • 7.7.2 Market Forecast (2025-2033)

8 Japan Antibiotics Market - Breakup by Spectrum of Activity

  • 8.1 Broad-Spectrum Antibiotics
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Narrow-Spectrum Antibiotics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Antibiotics Market - Breakup by Route of Administration

  • 9.1 Oral
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Parenteral
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Topical
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2019-2024)
    • 9.4.2 Market Forecast (2025-2033)

10 Japan Antibiotics Market - Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Forecast (2025-2033)
  • 10.2 Specialty Clinics
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Others
    • 10.3.1 Historical and Current Market Trends (2019-2024)
    • 10.3.2 Market Forecast (2025-2033)

11 Japan Antibiotics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Antibiotics Market - Industry Analysis

  • 13.1 Drivers, Restraints and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix